Next Article in Journal
Isolation, Culture and Comprehensive Characterization of Biological Properties of Human Urine-Derived Stem Cells
Previous Article in Journal
Upregulated Guanine Deaminase Is Involved in Hyperpigmentation of Seborrheic Keratosis via Uric Acid Release
Previous Article in Special Issue
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
 
 
Article

A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo

1
Department of Surgery, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan
2
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
3
Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan
*
Author to whom correspondence should be addressed.
Present address: Division of Natural Medicines, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japan.
Academic Editor: Sotiris K Hadjikakou
Int. J. Mol. Sci. 2021, 22(22), 12502; https://doi.org/10.3390/ijms222212502
Received: 20 September 2021 / Revised: 11 November 2021 / Accepted: 16 November 2021 / Published: 19 November 2021
(This article belongs to the Special Issue Progress on Multidrug Resistance Mechanisms in Cancer)
The ATP-binding cassette subfamily G member 2 (ABCG2) transporter is involved in the development of multidrug resistance in cancer patients. Many inhibitors of ABCG2 have been reported to enhance the chemosensitivity of cancer cells. However, none of these inhibitors are being used clinically. The aim of this study was to identify novel ABCG2 inhibitors by high-throughput screening of a chemical library. Among the 5812 compounds in the library, 23 compounds were selected in the first screening, using a fluorescent plate reader-based pheophorbide a (PhA) efflux assay. Thereafter, to validate these compounds, a flow cytometry-based PhA efflux assay was performed and 16 compounds were identified as potential inhibitors. A cytotoxic assay was then performed to assess the effect these 16 compounds had on ABCG2-mediated chemosensitivity. We found that the phenylfurocoumarin derivative (R)-9-(3,4-dimethoxyphenyl)-4-((3,3-dimethyloxiran-2-yl)methoxy)-7H-furo [3,2-g]chromen-7-one (PFC) significantly decreased the IC50 of SN-38 in HCT-116/BCRP colon cancer cells. In addition, PFC stimulated ABCG2-mediated ATP hydrolysis, suggesting that this compound interacts with the substrate-binding site of ABCG2. Furthermore, PFC reversed the resistance to irinotecan without causing toxicity in the ABCG2-overexpressing HCT-116/BCRP cell xenograft mouse model. In conclusion, PFC is a novel inhibitor of ABCG2 and has promise as a therapeutic to overcome ABCG2-mediated MDR, to improve the efficiency of cancer chemotherapy. View Full-Text
Keywords: ABCG2 inhibitor; multidrug resistance; phenylfurocoumarin; ABC transporter; chemosensitivity ABCG2 inhibitor; multidrug resistance; phenylfurocoumarin; ABC transporter; chemosensitivity
Show Figures

Figure 1

MDPI and ACS Style

Kokubo, S.; Ohnuma, S.; Murakami, M.; Kikuchi, H.; Funayama, S.; Suzuki, H.; Kajiwara, T.; Yamamura, A.; Karasawa, H.; Sugisawa, N.; Ohsawa, K.; Kano, K.; Aoki, J.; Doi, T.; Naitoh, T.; Ambudkar, S.V.; Unno, M. A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo. Int. J. Mol. Sci. 2021, 22, 12502. https://doi.org/10.3390/ijms222212502

AMA Style

Kokubo S, Ohnuma S, Murakami M, Kikuchi H, Funayama S, Suzuki H, Kajiwara T, Yamamura A, Karasawa H, Sugisawa N, Ohsawa K, Kano K, Aoki J, Doi T, Naitoh T, Ambudkar SV, Unno M. A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo. International Journal of Molecular Sciences. 2021; 22(22):12502. https://doi.org/10.3390/ijms222212502

Chicago/Turabian Style

Kokubo, Shoji, Shinobu Ohnuma, Megumi Murakami, Haruhisa Kikuchi, Shota Funayama, Hideyuki Suzuki, Taiki Kajiwara, Akihiro Yamamura, Hideaki Karasawa, Norihiko Sugisawa, Kosuke Ohsawa, Kuniyuki Kano, Junken Aoki, Takayuki Doi, Takeshi Naitoh, Suresh V. Ambudkar, and Michiaki Unno. 2021. "A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo" International Journal of Molecular Sciences 22, no. 22: 12502. https://doi.org/10.3390/ijms222212502

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop